Publicacions - IR Sant Pau

Cercar

01/09/2024 Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry

Fern ndez-Lozano, D, Dom nguez-Alvaro, M, Narvaez-Garc a, J, Garrido-Pu al, N, De Miguel, E, Estrada-Alarc n, P, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moriano, C, S nchez-Mart n, J, Calvo, I, Aldasoro, V, Alcazar, LA, Loricera, J, Moya, P, Garc a-Villanueva, M, S nchez-Alonso, F, Casta eda, S, Hern ndez, JL, Blanco-Alonso, R. Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment

G mez, MLI, Escudero, PG, L pez, BM, Dorta, AG, Frade-Sosa, B, Lizarzaburu, MS, R a-Figueroa, I, Su rez, DVF, de Miera, FJTS, Melero-Gonzalez, RB, Santos, DD, Miranda, JA, Belando, CG, Boselli, G, Boteanu, AL, Selaya, CC, Santos, CS, Alvarez, ED, Font, J, Alonso, ER, Aragu s, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, G mez, IV, Vela-Casasempere, P, Merino, C, Mart nez, MI, Beriain, JAH, Roman, AMR, Calvo-Al n, J. Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study

Mysler, E, Ignatenko, S, Gordienko, A, Cort s-Hern ndez, J, Agmon-Levin, N, Narongroeknawin, P, Romanowska-Prochnicka, K, Shen, N, Cifersk , H, Kodera, M, Wei, JCC, Leszczynski, P, Lan, JL, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Dai, L, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, Magallares, BP, Sengupta, T, Sips, C, Lau, C, Avrameas, A, Oliver, SJ. Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease

Zhang, YL, Tedeschi, S, Abhishek, A, Hensey, O, Grossberg, D, Cai, K, Shea, B, Singh, J, Christensen, R, Serban, T, Cipolletta, E, Parperis, K, D az, C, McCarthy, G, Becce, F, Gheita, TA, Sirotti, S, Christiansen, SN, Tarancon, LC, Stamp, L, Abdel-Fattah, YH, Pascart, T, Filippou, G, Hong, LE, FitzGerald, J, Dalbeth, N. Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Effectiveness of Rituximab in IgG4 Related Disease

Lopez-Gutierrez, F, Loricera, J, Hormigos, C, Nu ez, DF, Rodriguez-Laguna, M, Albarado, PM, G mez, MLI, Corominas, H, Silva-D az, M, Arribas, GG, Garcia-Aparicio, A, Urgelles, JF, Casafont-Sole, I, Calabuig, PM, Castaneda, E, Merino, C, Zas, R, Molina-Collada, J, Melero-Gonzalez, RB, Galindez-Agirregoikoa, E, Hern ndez-Mart n, A, Pantoja, L, Abascal, IB, Jovani, V, Valls-Pascual, E, V zquez, NM, Gallego-Flores, A, Ra a, NC, Veroz, R, Andres, M, Casta eda, S, Blanco-Alonso, R. Effectiveness of Rituximab in IgG4 Related Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis

Guerrero, MR, Moriano, C, Santos, CS, Herranz, LS, Garcia, JJ, Barranco, IC, Alvarez, ED. Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study

De Silva, C, D az, C, Gamble, G, Horne, A, Doyle, A, Stamp, L, Dalbeth, N. Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases

Quevedo-Rodr guez, A, Otero-Varela, L, S nchez-Alonso, F, P rez-Vera, Y, Manero-Ruiz, J, Campos-Fern ndez, C, Manrique-Arija, S, Vela-Casasempere, P, Mera-Varela, A, D az, C, Movasat, A, Garcia-Magallon, B, Ros-Vilamaj , I, Perez-Garcia, C, Castrejon, I. Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort

D'Alessandro, R, Rodolfi, S, Calot, A, Bebear, L, Campochiaro, C, Codullo, V, Del Galdo, F, Barranco, IC, Zanatta, E, Randone, SB, Boleto, G, Raffray, L, Chatelus, E, Cacoub, P, Le Joncour, A, Airo, P, Santos, CS, Lescoat, A, Avouac, J, Denton, C, Allanore, Y. Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study

Avil s, A, Plaza, Z, S nchez-Alonso, F, Casta eda, S, Fernandez-Gutierrez, B, D az, C, Font, P, Martinez, O, Giner, E, Senabre, JM, Rueda, A, Perez, A, Sanchez, G, Gonzalez, C, Garc a, J, Llorca, J, Gonzalez-Gay, MA, Andres, M. Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients

Escudero, PG, G mez, MLI, L pez, BM, Santos, DD, de Miera, FJTS, Dorta, AG, Beriain, JAH, R a-Figueroa, I, Santos, CS, Alvarez, ED, Mart nez, MI, Frade-Sosa, B, Urgelles, JF, Lizarzaburu, MS, Alonso, ER, Aragu s, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, Merino, C, Vela-Casasempere, P, G mez, IV, Filloy, JAM, Melero-Gonzalez, RB, Belando, CG, Boselli, G, Boteanu, AL, Su rez, DVF, Selaya, CC, Roman, AMR, Calvo-Al n, J. Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 [Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.

Rivera-Díaz R, Carrascosa Carrillo JM, Alfonso Zamora S, Navarro Valdivieso JP, Muñoz Cabello B, Ros Abarca S, Soria de Francisco JM, Daudén Tello E. [Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.. Actas Dermo-Sifiliograficas. 2024; 115(8)DOI:10.1016/j.ad.2024.07.012. PMID:38972580. IF:(Q/D).

01/05/2024 Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk

Santos, CS, Oliveira, MM, Solari, PN, Mateus, P, Santos, MJ, Corominas, H, Castro, CA, Alvarez, ED. Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk. Reumatologia Clinica. 2024; 20(5)DOI:10.1016/j.reuma.2024.01.002. PMID:38880551. IF:(Q/D).

01/04/2024 3D-DXA based finite element modelling for femur strength prediction: evaluation against QCT.

Qasim, M, Picazo, ML, Wills, CR, Noailly, J, Di Gregorio, S, Barquero, LMD, Sierra, JM, Humbert, L. 3D-DXA based finite element modelling for femur strength prediction: evaluation against QCT.. JOURNAL OF CLINICAL DENSITOMETRY. 2024; 27(2)DOI:10.1016/j.jocd.2024.101471. PMID:38306806. IF:1.600(Q4/9D).

01/04/2024 SER recommendations on treatment of refractory Behc , et's syndrome

Morales, CM, Gil, JG, García, NB, Varillas, JLM, del Río, VC, Alvarado, PM, García, FJN, Espinosa, G, Fontecha, PDD, Rodríguez, MG, Arranz, JM, Gómez, ML, Hernández, FMF, Trujillo, MM, Sobrín, RD, Sánchez, JIM, Manzano, JM, Cuba, JS. SER recommendations on treatment of refractory Behc , et's syndrome. Reumatologia Clinica. 2024; 20(4)DOI:10.1016/j.reuma.2023.12.001. PMID:38614885. IF:(Q/D).

01/03/2024 Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

Fernández-Lozano, D, Hernández-Rodríguez, I, Narvaez, J, Domínguez-Alvaro, M, De Miguel, E, Silva-Díaz, M, Belzunegui, JM, Morales, CM, Sánchez, J, Galíndez-Agirregoikoa, E, Aldaroso, V, Abasolo, L, Loricera, J, Garrido-Puñal, N, Alvarado, PM, Larena, C, Navarro, VA, Calvet, J, Casafont-Solé, I, Ortiz-Sanjuán, F, Monte, TCS, Castañeda, S, Blanco, R. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register. RMD Open. 2024; 10(1)DOI:10.1136/rmdopen-2023-003824. PMID:38531620. IF:4.700(Q1/1D).

01/03/2024 Persistentsciatic artery, an uncommon cause of femoropopliteal occlusion

Casademont, EB, Molina, JM. Persistentsciatic artery, an uncommon cause of femoropopliteal occlusion. Angiologia. 2024; 76(2)DOI:10.20960/angiologia.00496. PMID:. IF:(Q/D).

26/02/2024 Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome: a 3-year follow-up cohort study

Park, HS, Martínez-Martínez, L, López, BM, Castellví, I, Moya, P, Codes-Mendez, H, Sosa, NH, Diaz-Torne, C, Laiz, A, Sainz, L, Tandaipan, JL, Mariscal, A, Franco-Leyva, T, Casademont, J, Juarez, C, Corominas, H. Prognostic significance of lymphocytic foci composition in minor salivary gland biopsies for severe disease flare and severity in Sjögren's syndrome: a 3-year follow-up cohort study. Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1332924. PMID:38469314. IF:5.900(Q1/2D).

01/02/2024 Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

Molina-Collada, J, Alonso, F, Otero, L, Bohórquez, C, Torné, CD, García, CP, Madrigal, JMB, Vela, P, Alvaro-Gracia, JM, Castrejón, I. Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024; 64DOI:10.1016/j.semarthrit.2023.152341. PMID:38128174. IF:4.400(Q1/1D).

01/02/2024 Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study

López-Medina, C, Calvo-Gutiérrez, J, Abalos-Aguilera, MC, Cepas, F, Plasencia-Rodríguez, C, Martínez-Feito, A, Balsa, A, Faré-García, R, Juan-Mas, A, Ruiz-Esquide, V, Sainz, L, Díaz-Torné, C, Godoy-Navarrete, FJ, Añón-Oñate, I, Mena-Vázquez, N, Manrique-Arija, S, Moreno-García, MS, Ortega-Castro, R, Escudero-Contreras, A. Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study. RMD Open. 2024; 10(1)DOI:10.1136/rmdopen-2023-003975. PMID:38395455. IF:4.700(Q1/1D).

20/01/2024 Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry

Molina-Collada, J, Domínguez-Alvaro, M, Melero-González, RB, Fernández-Fernández, E, Silva-Díaz, M, Valero, JA, González, I, Martín, JS, Narváez, J, Calvo, I, Mendizábal, J, Alcázar, LA, Loricera, J, Ruíz-Román, A, Moya, P, Cabañas, MT, Estrada, P, Prado-Galbarro, FJ, Castañeda, S, Blanco, R. Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry. RHEUMATOLOGY. 2024; DOI:10.1093/rheumatology/keae042. PMID:38244610. IF:4.400(Q1/1D).

03/01/2024 Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing's syndrome using quantitative computed tomography-based finite element analysis

Giuliodori, A, Soudah, E, Malouf, J, Martel-Duguech, L, Amodru, V, Gil, J, Hernandez, JA, Domingo, MP, Webb, SM, Valassi, E. Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing's syndrome using quantitative computed tomography-based finite element analysis. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2024; 190(1)DOI:10.1093/ejendo/lvae004. PMID:38285633. IF:5.200(Q1/2D).

01/01/2024 Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia

Clotet-Vidal, S, Prieto, MES, Llorach, PD, Gutiérrez, AS, Pou, JC, Bonafonte, OHT. Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia. Nutrients. 2024; 16(1)DOI:10.3390/nu16010011. PMID:38201841. IF:5.000(Q1/2D).

01/01/2024 A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis

Figueras, I, Feito, M, García-Bustinduy, M, Monte-Boquet, E, Ros, S, Zaragoza, V, De Tena, AL, De Frutos, FJO. A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.18255. PMID:38566531. IF:3.700(Q1/2D).

01/12/2023 Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.

Balsa A, Díaz Del Campo Fontecha P, Silva Fernández L, Valencia Martín J, Nistal Martínez V, León Vázquez F, Hernández Hernández MV, Corominas H, Cáliz Cáliz R, Aguado García JM, Candelas Rodríguez G, Ibargoyen Roteta N, Martí Carvajal A, Plana Farras MN, Puñal Riobóo J, Park HS, Triñanes Pego Y, Villaverde García V. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis.. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reumae.2023.07.004. PMID:38008602. IF:(Q/D).

01/11/2025 Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study

De Silva, C, Díaz-Torné, C, Gamble, G, Horne, A, Doyle, A, Stamp, LK, Dalbeth, N. Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study. RHEUMATOLOGY. 2025; 64(11)DOI:10.1093/rheumatology/keaf347. PMID:40581776. IF:4.400(Q1/1D).

21/05/2025 TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS

Vidal-Montal, P, Fabregat, A, Heredia, S, Bernardez, J, Magallares, BP, Gómez-Puerta, J, Frade-Sosa, B, Nolla, JM, Narváez, J. TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS. JOURNAL OF RHEUMATOLOGY. 2025; 52DOI:. PMID:. IF:3.400(Q2/3D).

01/01/2025 Gout therapy updated

McCarty, KL, Gaffo, AL, Diaz-Torne, C. Gout therapy updated. Therapeutic Advances in Musculoskeletal Disease. 2025; 17DOI:10.1177/1759720X251384584. PMID:41146690. IF:4.100(Q1/3D).

03/10/2021 Consensus on the treatment of allergic asthma with sublingual house dust mite immunotherapy in the field of pneumology

Plaza, V, Arnedillo, A, Blanco-Aparicio, M, Ignacio, JM, Urrutia, I. Consensus on the treatment of allergic asthma with sublingual house dust mite immunotherapy in the field of pneumology. Expert Review of Respiratory Medicine. 2021; 15(10)DOI:10.1080/17476348.2021.1942846. PMID:34128758. IF:4.300(Q2/5D).

01/09/2021 Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD

de-Torres, JP, O'Donnell, DE, Marin, JM, Cabrera, C, Casanova, C, Marin, M, Ezponda, A, Cosio, BG, Martinez, C, Solanes, I, Fuster, A, Neder, JA, Gonzalez-Gutierrez, J, Celli, BR. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD. CHEST. 2021; 160(3)DOI:10.1016/j.chest.2021.04.033. PMID:33901498. IF:11.393(Q1/1D).

01/08/2021 Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD Importance of Sex

Casanova, C, Gonzalez-Davila, E, Martinez-Gonzalez, C, Cosio, BG, Fuster, A, Feu, N, Solanes, I, Cabrera, C, Marin, JM, Balcells, E, Peces-Barba, G, de Torres, JP, Marin-Oto, M, Calle, M, Golpe, R, Ojeda, E, Divo, M, Pinto-Plata, V, Amado, C, Lopez-Campos, JL, Celli, BR. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD Importance of Sex. CHEST. 2021; 160(2)DOI:10.1016/j.chest.2021.03.069. PMID:33878339. IF:11.393(Q1/1D).

01/08/2021 Asthmatic subjects stratification using autonomic nervous system information

Milagro, J, Soto-Retes, L, Giner, J, Varon, C, Laguna, P, Bailon, R, Plaza, V, Gil, E. Asthmatic subjects stratification using autonomic nervous system information. Biomedical Signal Processing and Control. 2021; 69DOI:10.1016/j.bspc.2021.102802. PMID:. IF:5.076(Q2/4D).

01/08/2021 Non-Infectious Granulomatous Lung Disease : Imaging Findings with Pathologic Correlation

Franquet, T, Franks, TJ, Galvin, JR, Marchiori, E, Gimenez, A, Mazzini, S, Johkoh, T, Lee, KS. Non-Infectious Granulomatous Lung Disease : Imaging Findings with Pathologic Correlation. KOREAN JOURNAL OF RADIOLOGY. 2021; 22(8)DOI:10.3348/kjr.2020.1082. PMID:34132073. IF:7.109(Q1/2D).

01/11/2022 Tapia's syndrome and pronation in a patient with pneumonia due to COVID-19: About a case

Romano Cardozo A., Ruiz I., de la Rosa Carrillo D., Peñacoba P.. Tapia's syndrome and pronation in a patient with pneumonia due to COVID-19: About a case. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(9)DOI:10.1016/j.eimc.2021.06.019. PMID:35729048. IF:2.500(Q4/8D).

01/08/2022 Transbronchial Cryobiopsy Bohemian Rhapsody

Torrego A., Pajares V., Maldonado F., Hetzel J.. Transbronchial Cryobiopsy Bohemian Rhapsody. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(8)DOI:10.1016/j.arbres.2021.08.004. PMID:35312593. IF:8.000(Q1/2D).

03/06/2022 Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis

Rivera, CM, Crespo-Lessman, A, Arismendi, E, Munoz-Esquerre, M, Aguilar, X, Ausin, P, Bobolea, I, Duch, GD, Teixido, RP, Talaverano, GS, Sabardia, AS, Gall, XM. Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis. JOURNAL OF ASTHMA. 2022; 59(6)DOI:10.1080/02770903.2021.1917605. PMID:33882776. IF:1.900(Q4/8D).

01/03/2022 Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension

Sapina-Beltran, E, Benitez, ID, Torres, G, Fortuna-Gutierrez, AM, Marquez, PP, Masa, JF, Drager, LF, Cabrini, M, Felez, M, Vazquez, S, Abad, J, Lee, C, Garcia-Rio, F, Casitas, R, Mediano, O, Peralta, SR, Martinez, D, Sanchez-de-la-Torre, M, Barbe, F, Dalmases, M. Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension. HYPERTENSION RESEARCH. 2022; 45(3)DOI:10.1038/s41440-021-00762-7. PMID:34952953. IF:5.400(Q2/3D).

01/03/2022 Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort

Baptista-Serna L., Rodrigo-Muñoz J.M., Mínguez P., Valverde-Monge M., Arismendi E., Barranco P., Barroso B., Bobolea I., Cañas J.A., Cárdaba B., Cruz M.J., Curto E., Domínguez-Ortega J., García-Latorre R., González-Barcala F.J., Martínez-Rivera C., Mullol J., Muñoz X., Olaguibel J.M., Picado C., Plaza V., Quirce S., Rial M.J., Sastre B., Soto L., Valero A., del Pozo V., Sastre J.. Anxiety and body mass index affect asthma control: data from a prospective Spanish cohort. Journal of Allergy and Clinical Immunology-In Practice. 2022; 10(3)DOI:10.1016/j.jaip.2021.10.013. PMID:34673289. IF:9.400(Q1/2D).

01/02/2022 Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

Bermudo, G, Suarez-Cuartin, G, Rivera-Ortega, P, Rodriguez-Portal, JA, Sauleda, J, Nunez, B, Castillo, D, Aburto, M, Portillo, K, Balcells, E, Badenes-Bonet, D, Valenzuela, C, Fernandez-Fabrellas, E, Gonzalez-Budino, T, Cano, E, Acosta, O, Leiro-Fernandez, V, Romero, A, Planas-Cerezales, L, Villar, A, Moreno, A, Laporta, R, Vicens-Zygmunt, V, Shull, J, Franquet, T, Luburich, P, Molina-Molina, M. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(2)DOI:10.1016/j.arbres.2021.03.018. PMID:33895005. IF:8.000(Q1/2D).

01/02/2022 Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies

Plaza, V, Alobid, I, Alvarez, C, Blanco, M, Ferreira, J, Garcia, G, Gomez-Outes, A, Gomez, F, Hidalgo, A, Korta, J, Molina, J, Pellegrini, FJ, Perez, M, Plaza, J, Praena, M, Quirce, S, Sanz, J. Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(2)DOI:10.1016/j.arbres.2021.05.010. PMID:34167859. IF:8.000(Q1/2D).